Christopher D. Sarsons

622 total citations
15 papers, 485 citations indexed

About

Christopher D. Sarsons is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Christopher D. Sarsons has authored 15 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Christopher D. Sarsons's work include Protein Degradation and Inhibitors (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Peptidase Inhibition and Analysis (3 papers). Christopher D. Sarsons is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Nanoparticle-Based Drug Delivery (3 papers) and Peptidase Inhibition and Analysis (3 papers). Christopher D. Sarsons collaborates with scholars based in Canada, United States and Egypt. Christopher D. Sarsons's co-authors include Kristina D. Rinker, David T. Cramb, David Hwang, Juan Chen, Jonathan V. Rocheleau, Gang Zheng, Warren C. W. Chan, Qin Dai, Edward A. Sykes and Dean Gilham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and RSC Advances.

In The Last Decade

Christopher D. Sarsons

15 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher D. Sarsons Canada	8	220	182	163	73	35	15	485
Eric M. Mastria United States	8	149 0.7×	236 1.3×	153 0.9×	46 0.6×	60 1.7×	12	499
Xinzhu Shan China	9	257 1.2×	172 0.9×	322 2.0×	102 1.4×	51 1.5×	9	585
Tian-Lu Cheng Taiwan	8	280 1.3×	238 1.3×	156 1.0×	38 0.5×	97 2.8×	10	602
Rufang Liao China	11	179 0.8×	145 0.8×	245 1.5×	120 1.6×	25 0.7×	13	583
Aida Varela-Moreira Netherlands	12	202 0.9×	274 1.5×	149 0.9×	48 0.7×	49 1.4×	16	507
Matteo Monieri Italy	10	176 0.8×	135 0.7×	102 0.6×	34 0.5×	46 1.3×	15	432
Lu Guo China	17	202 0.9×	167 0.9×	341 2.1×	80 1.1×	44 1.3×	33	595
Francesca Pierigè Italy	14	323 1.5×	216 1.2×	315 1.9×	80 1.1×	65 1.9×	30	851
Audrey Thomas France	4	284 1.3×	54 0.3×	201 1.2×	55 0.8×	18 0.5×	7	461
Tanner K. Hill United States	10	146 0.7×	186 1.0×	261 1.6×	73 1.0×	10 0.3×	11	516

Countries citing papers authored by Christopher D. Sarsons

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Sarsons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Sarsons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Sarsons more than expected).

Fields of papers citing papers by Christopher D. Sarsons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Sarsons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Sarsons. The network helps show where Christopher D. Sarsons may publish in the future.

Co-authorship network of co-authors of Christopher D. Sarsons

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Sarsons. A scholar is included among the top collaborators of Christopher D. Sarsons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Sarsons. Christopher D. Sarsons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Gilham, Dean, Sylwia Wasiak, Brooke D. Rakai, et al.. (2023). Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines. 11(6). 1663–1663. 6 indexed citations

Fu, Li, Dean Gilham, Stephanie C. Stotz, et al.. (2023). Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation. International Immunopharmacology. 117. 109929–109929. 2 indexed citations

Sarsons, Christopher D., Dean Gilham, Laura Tsujikawa, et al.. (2023). Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells. Biomedicines. 11(10). 2683–2683. 1 indexed citations

Tsujikawa, Laura, Olesya A. Kharenko, Stephanie C. Stotz, et al.. (2022). Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective BETi are strictly epigenetic transcriptional regulators. Biomedicine & Pharmacotherapy. 152. 113230–113230. 10 indexed citations

Gilham, Dean, Li Fu, Laura Tsujikawa, et al.. (2020). Abstract 14112: Apabetalone (RVX-208) Reduces ACE2 Expression in Human Cell Culture Systems, Which Could Attenuate SARS-CoV-2 Viral Entry. Circulation. 142(Suppl_3). 1 indexed citations

Tsujikawa, Laura, Li Fu, Christopher Halliday, et al.. (2019). Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism. Clinical Epigenetics. 11(1). 102–102. 90 indexed citations

Gilham, Dean, Laura Tsujikawa, Christopher D. Sarsons, et al.. (2018). Apabetalone downregulates factors and pathways associated with vascular calcification. Atherosclerosis. 280. 75–84. 49 indexed citations

Labouta, Hagar I., Marta Gómez-Garcı́a, Christopher D. Sarsons, et al.. (2018). Surface-grafted polyethylene glycol conformation impacts the transport of PEG-functionalized liposomes through a tumour extracellular matrix model. RSC Advances. 8(14). 7697–7708. 45 indexed citations

Labouta, Hagar I., et al.. (2018). Understanding and improving assays for cytotoxicity of nanoparticles: what really matters?. RSC Advances. 8(41). 23027–23039. 15 indexed citations

10.

Sykes, Edward A., Qin Dai, Christopher D. Sarsons, et al.. (2016). Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proceedings of the National Academy of Sciences. 113(9). E1142–51. 221 indexed citations

11.

Jiang, Xiaoyu, Christopher D. Sarsons, Marta Gómez-Garcı́a, et al.. (2016). Quantum dot interactions and flow effects in angiogenic zebrafish ( Danio rerio ) vessels and human endothelial cells. Nanomedicine Nanotechnology Biology and Medicine. 13(3). 999–1010. 22 indexed citations

12.

Clements, Thomas W., Christopher D. Sarsons, Casey M. Platnich, et al.. (2016). Maltol‐Functionalized Fe ₃ O ₄ Nanoparticles as T ₂ Magnetic Resonance Imaging Contrast Agents. ChemistrySelect. 1(8). 1602–1606. 11 indexed citations

13.

Sarsons, Christopher D., et al.. (2015). RELATING QUANTUM DOT ASSOCIATION WITH HUMAN ENDOTHELIAL CELLS WITH THEIR CYTOTOXIC EFFECTS. 5(1). 1 indexed citations

14.

Sarsons, Christopher D., et al.. (2014). Testing Nanoparticles for Angiogenesis-Related Disease: Charting the Fastest Route to the Clinic. Journal of Biomedical Nanotechnology. 10(9). 1641–1676. 4 indexed citations

15.

Sarsons, Christopher D., et al.. (2012). Pd(η³-1-PhC₃H₄)(η⁵-C₅H₅), an Unusually Effective Catalyst Precursor for Heck–Mizoroki and Sonogashira Cross-Coupling Reactions Catalyzed by Bis-Phosphine Palladium(0) Compounds. Organometallics. 32(1). 9–11. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact